Fact-checked by Grok 2 weeks ago

SNAP25

SNAP-25 (synaptosomal-associated protein 25) is a presynaptic t-SNARE protein essential for the calcium-triggered exocytosis of synaptic vesicles and the regulated release of neurotransmitters in neurons. Encoded by the SNAP25 gene on human chromosome 20p12.2, it consists of 16 exons and produces a 206-amino-acid protein with a molecular weight of approximately 25 kDa. Unlike typical SNARE proteins with transmembrane domains, SNAP-25 anchors to the cytosolic face of the plasma membrane through palmitoylation of four cysteine residues in its central linker domain, allowing it to participate in membrane fusion without direct transmembrane insertion. SNAP-25 functions primarily by forming a core SNARE complex with syntaxin-1 (another t-SNARE) and VAMP2/synaptobrevin (a v-SNARE on synaptic vesicles), which zippers together to bring vesicle and plasma membranes into close proximity, driving and release. Its structure includes two SNARE motifs (SN1 and SN2) connected by a flexible linker domain of approximately 56 , which modulates pore dynamics, secretion kinetics, and interactions with regulatory proteins. The protein exists in two major isoforms, SNAP-25A and SNAP-25B, generated by of 5; SNAP-25A predominates during embryonic development, while SNAP-25B becomes the primary form in mature neurons, influencing synaptic transmission efficiency. Expression of SNAP-25 is highly restricted to neural tissues, with the highest levels in the (RPKM ~418.5), particularly in presynaptic terminals of cortical, hippocampal, and cerebellar neurons, though lower postsynaptic expression has been detected. Beyond its classical presynaptic role, emerging evidence indicates postsynaptic functions, including regulation of NMDA and trafficking, dendritic morphogenesis via interactions with p140Cap and PSD-95, and . Dysfunction in SNAP-25 is implicated in various neurological and psychiatric disorders; for instance, mutations cause congenital myasthenic syndrome 18 (CMS18) and developmental epileptic encephalopathy 117 (DEE117), both characterized by impaired synaptic transmission. Recent studies (as of 2024) have further elucidated how DEE-associated variants alter SNARE complex stability. Polymorphisms in SNAP25 are associated with schizophrenia, bipolar disorder, attention-deficit/hyperactivity disorder (ADHD), and epilepsy, often through altered expression or complex formation that disrupts synaptic signaling.

Gene and expression

Genomic organization

The SNAP25 is located on the short arm of at cytogenetic band p12.2, with genomic coordinates spanning from 10,218,830 to 10,307,418 (GRCh38 assembly), covering approximately 89 kb. The orthologous Snap25 in mouse is situated on (positions 136,555,373-136,624,348, GRCm39 assembly), spanning about 69 kb. The SNAP25 consists of 9 units, including mutually exclusive exons 5a and 5b, and the canonical transcript (ENST00000254976.11) utilizes 8 exons, with primarily involving exons 5a and 5b that contribute to isoform diversity. boundaries are structured such that exons 1-4 and 6-8 encode regions flanking the variable exon 5, while specific exons align with sequences that translate into structural motifs essential for protein function, such as coiled-coil domains in exons 4 and 5. This organization supports the generation of two major protein isoforms, SNAP25A and SNAP25B, through the inclusion of either exon 5a or 5b. SNAP25 exhibits strong evolutionary conservation across vertebrates, with sequence identity exceeding 99% between and orthologs, reflecting its critical role in conserved cellular processes. Homologs are also present in , including the gene in Drosophila melanogaster, which spans over 120 kb with 8 exons and demonstrates functional similarity in trafficking. This conservation underscores the ancient origins of the SNAP25 family, traceable to early metazoans. A notable polymorphism in the SNAP25 is rs3746544 (T>G) located in the 3' (3'-UTR), which influences mRNA stability and expression levels by altering binding sites for microRNAs such as miR-641. The minor G has been shown to reduce SNAP25 transcript abundance in neuronal s.

Expression patterns and regulation

SNAP25 exhibits high expression in neuronal s, particularly within presynaptic terminals of the central and peripheral nervous systems, where it is enriched in synaptic vesicles and membranes. Lower levels of expression are observed in neuroendocrine cells and select non-neuronal s, such as pancreatic beta cells in the islets of Langerhans, supporting regulated in these secretory systems. According to expression from the Protein Atlas and NCBI, SNAP25 shows restricted specificity toward the , with an average RPKM of 418.5 in neural s compared to minimal detection elsewhere. During development, SNAP25 expression is upregulated in conjunction with , starting from low levels in embryonic and progressively increasing to peak in adulthood. This temporal pattern is evident across key regions, including the and , where the SNAP25B isoform predominates in mature neurons, reflecting enhanced synaptic maturation and plasticity. Fetal expression data indicate presence in as early as 10-20 weeks , with broader but lower detection in other organs like adrenal and heart. The expression of SNAP25 is tightly regulated by core promoters and distal enhancers that drive neuron-specific transcription, with the repressor element 1-silencing (REST/NRSF) playing a key role in silencing the in non-neuronal cells. Epigenetic modifications, including histone acetylation at promoter regions and patterns, further modulate neuronal expression by maintaining an open state in brain tissues while repressing it elsewhere. Alternative promoter usage contributes to the generation of tissue-specific transcripts, enabling differential isoform production that aligns with developmental and cellular contexts.

Protein structure

Domains and motifs

The SNAP25 protein comprises 206 in its primary isoform, exhibiting a modular without a that distinguishes it from other SNARE family members. Central to its structure are two SNARE motifs, SN1 and SN2, which adopt alpha-helical conformations and contribute to the formation of parallel coiled-coil bundles in the SNARE complex. These motifs enable SNAP25 to act as a Q-SNARE, with each containing a conserved residue in the characteristic Q-SNARE signature sequence that facilitates heterotetrameric assembly. The N-terminal domain houses the SN1 motif, while the C-terminal domain contains the SN2 motif, connected by a flexible linker that imparts structural versatility. The cysteine-rich linker region, spanning approximately 85-140, includes key palmitoylation sites at Cys85, Cys88, Cys90, and Cys92, which support membrane anchoring through lipid modification. Crystal structures of SNAP25 in complex with partner SNAREs, such as those deposited in the (e.g., PDB entry 1JTH), reveal alpha-helical bundles where the SN1 and SN2 helices from SNAP25 integrate into an elongated four-helix motif, underscoring the protein's role in stable complex formation.

Isoforms and post-translational modifications

SNAP25 is expressed as two primary isoforms, SNAP-25A and SNAP-25B, arising from of mutually exclusive exons 5A and 5B within the SNAP25 gene. These isoforms share identical sequences except for nine differences in a central linker region between the two SNARE motifs. SNAP-25A predominates during embryonic and early postnatal brain development, supporting initial , whereas SNAP-25B expression increases postnatally and becomes the major isoform in mature neurons, particularly in the and cortex. Post-translational modifications significantly influence SNAP25 localization, stability, and activity. Palmitoylation at four residues (Cys85, Cys88, Cys90, and Cys92) in the anchors SNAP25 to the plasma membrane, enabling its integration into fusion machinery; dynamic depalmitoylation and repalmitoylation by DHHC enzymes regulate this process. Phosphorylation at serine 187 by (PKC) enhances function in , promoting SNARE complex assembly and synaptic facilitation without altering membrane targeting. Ubiquitination modulates stability, as activity-dependent polyubiquitination targets it for proteasomal degradation, preventing accumulation and maintaining synaptic . The molecular chaperone Hsc70, often in complex with cysteine string protein α (CSPα), facilitates SNAP25 folding and prevents its aggregation into non-functional states, a process critical for preserving . Compared to SNAP-25A, the SNAP-25B isoform supports more efficient fusion, exhibiting two- to three-fold greater efficacy in driving release in reconstituted systems and neuronal models.

Biological function

Role in SNARE complex and exocytosis

SNAP25 functions as a principal t-SNARE protein anchored to the presynaptic plasma membrane, where it heterodimerizes with syntaxin-1 to create a acceptor for the v-SNARE VAMP2 (also known as synaptobrevin-2) on synaptic vesicles, thereby mediating Ca²⁺-dependent release through . This ternary SNARE forms a stable four-helix bundle that zippers from N- to C-termini, drawing the vesicle and plasma membranes into close apposition to overcome the energy barrier for fusion. Unlike syntaxin-1 and VAMP2, which each contribute a single α-helix and possess transmembrane domains, SNAP25 provides two parallel SNARE motifs linked by a flexible linker containing residues for palmitoylation, allowing soluble and membrane attachment via palmitoylation rather than a transmembrane anchor. The formation of this SNARE complex is critical for synaptic vesicle priming at the active zone, positioning vesicles in a release-ready state competent for rapid upon calcium influx, and its disassembly post- enables . Genetic of SNAP25 in mice results in perinatal lethality attributable to profound defects in evoked synaptic transmission, with near-complete loss of Ca²⁺-triggered release while spontaneous miniature events persist at reduced levels, underscoring its indispensable role in regulated . SNAP25 briefly interacts with syntaxin-1 and VAMP2 during complex assembly to drive these processes. Proteomic quantification reveals SNAP25 as one of the most abundant presynaptic proteins, with approximately 100–200 molecules localized per active zone to support high-fidelity release, and the SNARE complex enables fusion kinetics on the sub-millisecond timescale synchronized to opening. This molecular architecture ensures efficient, synchronous discharge essential for neural signaling.

Regulatory mechanisms and emerging roles

The activity of SNAP25 is tightly regulated post-fusion by the NSF in with α-SNAP, which disassembles SNARE complexes to recycle components for subsequent rounds of . NSF binds to the SNARE via α-SNAP, and drives the mechanical separation of SNAP25, syntaxin-1, and VAMP2, preventing their persistent association and enabling SNARE reuse. This disassembly is essential for maintaining efficient synaptic transmission, as persistent SNARE complexes would otherwise inhibit further vesicle priming. Prior to fusion, SNAP25 function is modulated by accessory proteins such as Munc18-1 and complexin, which clamp SNARE assembly to ensure calcium-triggered synchrony. Munc18-1 binds to the syntaxin-1/SNAP25 binary complex, stabilizing it in a pre-fusion state and preventing premature full zippering until Munc13-1 facilitates progression. Complexin further clamps this partially assembled SNARE complex by laterally binding to it, inhibiting spontaneous fusion while sensitizing the system to synaptotagmin-1 activation upon calcium influx. Recent studies have highlighted chaperone systems involving Hsc70 that maintain SNAP25 solubility and prevent aggregation, particularly under synaptic stress. The Hsc70 chaperone, in cooperation with CSPα, binds monomeric SNAP25 to keep it in an assembly-competent conformation, delaying its aggregation and ensuring availability for SNARE complex formation. This mechanism is critical for synaptic integrity, as SNAP25 aggregation disrupts and contributes to neurodegenerative pathologies. Emerging evidence points to postsynaptic roles for SNAP25 beyond presynaptic , including regulation of receptor trafficking and morphology. In hippocampal neurons, SNAP25 interacts with p140Cap to control endocytosis and stabilize density, influencing . Reduced SNAP25 levels increase PSD-95 mobility and impair morphogenesis, underscoring its contribution to postsynaptic architecture. In non-neuronal contexts, SNAP25 supports insulin secretion from pancreatic β-cells by forming SNARE complexes that mediate glucose-stimulated granule . SNAP25 isoforms, particularly SNAP-25b, enhance calcium-dependent insulin release, with deficiencies leading to altered granule dynamics and increased basal secretion. Botulinum cleavage of SNAP25 confirms its necessity, as it potently inhibits insulin similar to release. Structural studies from 2025 provide new insights into NSF-mediated remodeling of SNAP25-syntaxin complexes, revealing how NSF/α-SNAP disassembles non-fusogenic binary complexes to liberate syntaxin for Munc18/Munc13 action. Cryo-EM structures show NSF engaging a 2:1 syntaxin-SNAP25 complex, inducing conformational changes that promote SNARE recycling and at the active zone. These findings elucidate how such remodeling ensures rapid SNARE turnover essential for high-fidelity synaptic transmission.

Clinical significance in humans

Developmental and epileptic encephalopathies

Mutations in the SNAP25 gene are associated with developmental and epileptic 117 (DEE117; OMIM 616330), an autosomal dominant disorder primarily caused by de novo heterozygous variants that disrupt the protein's role in exocytosis. Deleterious variants, such as p.Val48Phe (V48F), p.Asp166Tyr (D166Y), and p.Ile67Asn (I67N), impair SNARE complex stability by altering key binding interfaces, including those with synaptotagmin-1, leading to defective release. These mutations are recurrent in affected individuals and have been identified through trio-based in cohorts of patients with early-onset . Clinically, SNAP25-related DEE117 manifests with severe neurological features, including infantile spasms in approximately 22% of cases, often accompanied by on (EEG). Onset of seizures typically occurs within the first year of life, with a median age of 12 months, and is frequently refractory to antiepileptic drugs. Affected individuals exhibit profound (universal in reported cases), , , and autism spectrum traits in about 17% of patients; additional features may include (33%), (19%), and . Brain imaging often reveals cerebral or mild , though findings are variable. The underlying involves reduced evoked release due to SNARE complex dysfunction, resulting in neuronal hyperexcitability and impaired synaptic . Recent studies using simulations have shown that these variants alter the energy landscape of synaptic ; for instance, V48F and D166Y lower the fusion energy barrier, promoting spontaneous release while diminishing the readily releasable pool, whereas I67N acts dominantly negative to increase the barrier and suppress release overall. This dual loss- and gain-of-function mechanism contributes to the epileptic and developmental arrest. relies on whole-exome or targeted sequencing to identify SNAP25 variants, supported by EEG and clinical evaluation. Currently, no targeted therapies exist; management is supportive, involving antiepileptic drugs (e.g., valproic acid or with partial response in some), , or corticosteroids for spasms, though outcomes remain poor.

Neurodevelopmental and psychiatric disorders

Single nucleotide polymorphisms (SNPs) in the SNAP25 gene have been implicated in the risk for attention-deficit/hyperactivity disorder (ADHD), with the rs1051312 variant showing consistent associations across studies. This SNP, located in the 3' untranslated region, influences SNAP25 expression and is linked to altered dopamine release in prefrontal cortical regions critical for attention and executive function. Meta-analyses of multiple cohorts indicate that carriers of the minor allele exhibit modestly increased ADHD risk, with odds ratios ranging from 1.14 to 1.19, highlighting its contribution as a common genetic factor rather than a deterministic one. In , the rs363039 has been associated with altered cortical SNAP25 expression, potentially disrupting synaptic transmission in prefrontal areas involved in and perception. Reduced SNAP25 levels in postmortem brain tissue from patients correlate with this variant, suggesting a role in synaptic hypofunction that exacerbates psychotic symptoms. For , the promoter region rs6039769 (also referred to as rs603976 in some datasets) is linked to early-onset cases, where the risk allele promotes higher SNAP25 expression in the , possibly leading to dysregulated release during manic episodes. These associations underscore SNAP25's involvement in psychiatric disorders through subtle changes. The underlying mechanisms involve partial from these common variants, resulting in mild synaptic deficits that accumulate to influence neurodevelopmental trajectories. Unlike rare monogenic mutations, these polymorphisms do not cause disorders in isolation but interact within polygenic networks to modulate trafficking and homeostasis. No evidence supports monogenic causality for ADHD, , or learning disabilities via SNAP25 alone.

Neurodegenerative diseases

SNAP25 plays a critical role in synaptic dysfunction underlying (AD), where reduced levels in brain tissue and serve as indicators of progressive synaptic loss. As a key component of the SNARE complex, diminished SNAP25 expression correlates with the severity of cognitive decline, with 2023 studies demonstrating its utility as a () for monitoring degeneration in AD patients. For instance, longitudinal analyses have shown that lower SNAP25 concentrations in synaptic fractions precede overt neuronal damage, highlighting its involvement in early pathological cascades. In pathophysiology, synaptic degeneration occurs prior to widespread neuronal loss, disrupting release and contributing to impairment. SNAP25 undergoes cleavage by during apoptotic processes in affected neurons, exacerbating deficits and amplifying synaptic vulnerability. This proteolytic modification, activated by amyloid-beta toxicity, further impairs SNARE complex assembly and is observed in preclinical models of . In (), aggregates interfere with SNAP25 palmitoylation, a essential for its membrane anchoring and function, thereby reducing vesicular and transmission. A 2025 review underscores this mechanism as a potential early therapeutic target, where restoring palmitoylation could mitigate synaptic pathology and slow disease progression. Clinically, CSF SNAP25 assays aid in diagnosing and , with significant level reductions—often 20-50%—evident in prodromal stages, enabling earlier intervention before substantial cognitive deficits emerge. These assays distinguish neurodegenerative synaptic loss from other conditions, though overlaps with psychiatric disorders like warrant cautious interpretation.

Toxin-mediated pathologies

Botulinum neurotoxins (BoNTs) serotypes A and E specifically target SNAP25, a key component of the SNARE complex essential for . BoNT/A cleaves SNAP25 at the between 197 and 198 (Q197-R198), while BoNT/E cleaves it between 180 and 181 (R180-I181). These cleavages truncate the C-terminal region of SNAP25, preventing the formation of functional SNARE complexes and thereby inhibiting release at neuromuscular junctions. In clinical botulism, primarily caused by ingestion or inhalation of BoNTs produced by Clostridium botulinum, the toxin's action on SNAP25 leads to through blockade of release from presynaptic terminals. Symptoms typically manifest as descending muscle weakness, starting with and progressing to respiratory and limb muscles, potentially resulting in if untreated. Infant botulism, the most common form in young children, arises from the germination of C. botulinum spores in the immature gut, where the bacteria produce toxin in situ, leading to similar paralytic effects. Therapeutically, purified BoNT/A (onabotulinumtoxinA) is widely used to treat conditions involving excessive muscle activity, such as cervical dystonia and chronic migraine, by locally injecting the toxin to induce targeted SNAP25 cleavage and temporary . The FDA has approved BoNT/A for cervical dystonia in adults, where it reduces abnormal head positioning and . For chronic migraine, prophylactic injections decrease frequency and severity, with effects mediated by SNAP25 truncation in peripheral sensory neurons. The duration of therapeutic from BoNT/A typically lasts 3-6 months, attributed to the persistence of the cleaved SNAP25 fragment and gradual resynthesis of intact protein. Recent studies highlight that BoNT/A cleavage of SNAP25 is often partial rather than complete, allowing residual SNARE function that contributes to gradual neuromuscular recovery without full resynthesis in some neuronal compartments. This acute, toxin-induced synaptic blockade differs mechanistically from endogenous protein dysregulation, with no pathological overlap in clinical presentation or progression.

Studies in model organisms

Invertebrate models

Studies in invertebrate model organisms, particularly Drosophila melanogaster and yeast, have provided key insights into the conserved roles of SNAP25 homologs in membrane fusion processes. In Drosophila, the SNAP25 ortholog, encoded by the Snap25 gene, is crucial for synaptic transmission at the neuromuscular junction. Null mutants of Snap25 are viable through the larval stage but fail to eclose as adults due to impaired neurotransmitter release, with compensation by the related protein SNAP-24 during early development. A temperature-sensitive allele, SNAP-25^{ts}, induces reversible paralysis at restrictive temperatures (29°C), demonstrating the protein's essential role in evoked synaptic vesicle exocytosis without affecting spontaneous release under certain conditions. Rescue experiments further highlight the functional conservation of SNAP25. Transgenic expression of wild-type SNAP25 fully restores viability and synaptic function in null or ts mutants, confirming its specificity in SNARE complex assembly. Due to approximately 61% identity between SNAP25 and human SNAP25, these findings underscore SNAP25's role in docking and priming synaptic vesicles for Ca^{2+}-triggered fusion, a conserved from invertebrates to humans. Evolutionary perspectives are deepened by studies in unicellular eukaryotes like , where the SNAP25 homolog Sec9p participates in a mediating of post-Golgi secretory vesicles to the plasma membrane. Unlike metazoan SNAP25, which is neuron-specific and membrane-anchored via palmitoylation, Sec9p lacks such targeting and supports general secretory fusion without neuronal specialization. This highlights SNAP25's ancestral role in intracellular trafficking, evolving toward specialized synaptic functions in higher organisms. Recent investigations in 2025 have elucidated of SNAP25-containing complexes in cellular models, revealing NSF-mediated remodeling that parallels in Drosophila synapses. NSF, an AAA+ , disassembles non-fusogenic binary syntaxin-SNAP25 complexes, liberating syntaxin for productive SNARE assembly and vesicle priming. In fly neuromuscular junctions, this process prevents off-pathway aggregates, ensuring efficient and mirroring NSF's quality-control function observed in mammalian synapses via cryo-EM structures of SNARE supercomplexes.

Vertebrate and mammalian models

Homozygous of SNAP25 in mice results in perinatal , with embryos viable until late but failing to survive postnatally due to severe impairments in and evoked release, highlighting SNAP25's essential role in vesicle trafficking. Heterozygous SNAP25 mice exhibit increased susceptibility to kainate-induced , spontaneous epileptiform activity in hippocampal slices, and cognitive deficits that are ameliorated by antiepileptic drugs like and , underscoring the protein's involvement in generation and synaptic function. Brain-specific conditional models further demonstrate synaptic deficits, elevated extracellular glutamate levels, contributing to behavioral abnormalities reminiscent of neuropsychiatric disorders. Isoform-specific models reveal differential roles of SNAP25 variants in mammalian . Mice expressing only the SNAP25A isoform (achieved via SNAP25B with SNAP25A knock-in) are viable but display spontaneous seizures, hyperactivity, anxiety-like behaviors in tests, and learning impairments in fear conditioning tasks, linking SNAP25 dysregulation to and attention-deficit/hyperactivity disorder (ADHD) models. These phenotypes arise from altered synaptic transmission and vesicle priming, with SNAP25B normally dominating in adult neurons for efficient , while SNAP25A suffices developmentally but leads to deficits when persistently expressed. SNAP25 heterozygous mice also serve as ADHD models, showing delayed motor , hyperactivity in open field tests, and attention deficits, supporting genetic contributions of SNAP25 to neurodevelopmental disorders. In , morpholino-mediated knockdown of SNAP25 disrupts synaptic transmission, impairs development, and induces characterized by reduced locomotion and uncoordinated swimming, phenotypes that mimic aspects of epileptic seizures and facilitate high-throughput drug screening for neurodevelopmental therapies. These models leverage zebrafish's optical transparency and rapid development to assess antiepileptic compounds, such as those targeting SNARE complex function, providing insights into SNAP25's conserved role in synaptic physiology. Recent /Cas9-engineered models have advanced understanding of SNAP25-related developmental and epileptic encephalopathies (). Patient-derived mutations like I67N, introduced via in induced pluripotent stem cell (iPSC)-derived neurons, recapitulate synaptic dysfunction and hyperexcitability, offering platforms to test therapeutic responses and model encephalopathies in mammalian cellular contexts. These approaches complement traditional knockouts by enabling precise variant-specific studies, revealing altered SNARE complex assembly and spontaneous release as key mechanisms in pathogenesis.

Protein interactions

Key binding partners

SNAP25, a key Q-SNARE protein, primarily interacts with other SNARE family members to facilitate fusion. Its core binding partners include syntaxin-1A and syntaxin-1B, which are plasma membrane Qa-SNAREs that bind SNAP25 through their respective SNARE motifs to form a stable binary complex on the presynaptic membrane. This interaction has been characterized with high , exhibiting a (Kd) of approximately 126 , as determined by quantitative binding assays on lipid bilayers. Another essential partner is VAMP2 (vesicle-associated membrane protein 2), an R-SNARE anchored to the membrane, which engages the syntaxin-1/SNAP25 acceptor complex to form the trans-SNARE complex that drives membrane fusion. The assembly of this ternary SNARE complex proceeds with stepwise zippering of SNARE motifs, resulting in overall binding affinities in the low nanomolar range, supported by co-immunoprecipitation (co-IP) studies confirming stable interactions in neuronal extracts. Among accessory proteins, Munc18-1 acts as a chaperone for syntaxin-1, indirectly influencing SNAP25 incorporation into the SNARE complex by stabilizing the closed conformation of syntaxin-1 prior to SNAP25 binding, as evidenced by co-IP experiments showing enhanced complex formation in the presence of Munc18-1. Complexin-1 and complexin-2 bind to the partially assembled SNARE complex involving SNAP25, functioning to clamp the complex and prevent premature fusion until calcium influx, with interactions verified through co-IP and binding assays in synaptic preparations. Synaptotagmin-1, the primary calcium sensor for , directly docks to the syntaxin-1/SNAP25 heterodimer via its domains, promoting calcium-triggered SNARE complex completion, as demonstrated by docking assays and co-IP in neuronal lysates. In contrast, SNAP-47, a related Qbc-SNARE with to SNAP25, can form SNARE complexes with syntaxin-1 and VAMP2 but does not significantly interact with or substitute for SNAP25 in neuronal contexts, based on experiments in SNAP25-deficient neurons showing minimal functional overlap. These interactions have been extensively mapped using techniques such as for initial partner identification and co-IP for validation in native systems, highlighting SNAP25's central role in the presynaptic interactome.

Functional complexes and pathways

SNAP25 serves as a key t-SNARE protein in the formation of the core SNARE complex, which drives fusion with the plasma membrane during release. It assembles with plasma membrane-anchored syntaxin-1 to form a stable binary t-SNARE complex, acting as an acceptor template for the v-SNARE synaptobrevin-2 (VAMP2) from the vesicle membrane. This ternary complex creates a four-helix bundle, where sequential N- to C-terminal zippering of VAMP2 generates approximately 85 k_BT of free energy to overcome the fusion barrier, with distinct kinetic steps: rapid N-terminal (~2×10^6 M^{-1}s^{-1}), a moderate middle-domain barrier (~5 k_BT), and higher energy costs for the C-terminal domain (~22 k_BT) and linker domain (~8 k_BT). Assembly pathways for the SNARE complex involving SNAP25 are tightly regulated by accessory proteins to ensure precise timing in . In the canonical t-SNARE pathway, the syntaxin-1/SNAP25 binary complex unfolds with ~17 k_BT energy, priming it for VAMP2 integration. An alternative Munc18-1-dependent pathway involves a preformed syntaxin-1/VAMP2 template on Munc18-1, where SNAP25 binds at ~5×10^5 M^{-1}s^{-1} and displaces Munc18-1 to complete the complex. Munc13-1 chaperones this process by recruiting SNAP25, opening closed syntaxin-1 conformers, and stabilizing intermediates, while complexin-1 clamps the partially zipped complex to prevent premature fusion until Ca^{2+}-synaptotagmin activation triggers full zippering. These pathways ensure SNAP25's role in Ca^{2+}-triggered, stimulus-evoked release at synapses. Beyond , SNAP25 participates in additional functional complexes modulating synaptic transmission. It interacts directly with voltage-gated calcium channels (e.g., N-type, P/Q-type, and L-type), forming complexes that negatively regulate Ca^{2+} influx to fine-tune presynaptic excitability. In postsynaptic compartments, SNAP25 influences receptor trafficking pathways; at Ser187 by promotes its association with NMDA receptors, enhancing their surface delivery and . Additionally, SNAP25 binds intersectin in endocytic complexes, supporting clathrin-mediated retrieval of synaptic vesicles and receptors like kainate GluK5 subunits via interactions with PICK1. These diverse roles highlight SNAP25's integration into broader membrane trafficking and signaling pathways at synapses.

References

  1. [1]
    SNAP25 synaptosome associated protein 25 [ (human)] - NCBI
    Sep 9, 2025 · This gene product is a presynaptic plasma membrane protein involved in the regulation of neurotransmitter release.
  2. [2]
    SNAP-25, a Known Presynaptic Protein with Emerging Postsynaptic ...
    Mar 24, 2016 · SNAP-25 is a component of the SNARE protein complex, which is involved in the exocytotic release of neurotransmitters during synaptic ...
  3. [3]
    Roles for the SNAP25 linker domain in the fusion pore and a ...
    Jul 28, 2020 · The domain in SNAP25 that links its two SNARE motifs plays important roles in fusion pore formation, secretion kinetics, and the formation ...<|control11|><|separator|>
  4. [4]
    600322 - SYNAPTOSOMAL-ASSOCIATED PROTEIN, 25-KD; SNAP25
    SNAP25 is a 25-kD protein of 206 amino acids. Bark and Wilson (1994) cloned 2 isoforms of SNAP25, SNAP25a and SNAP25b, from human temporal cortex and fetal ...
  5. [5]
  6. [6]
    SNAP25 - Synaptosomal-associated protein 25 | UniProtKB - UniProt
    Function · t-SNARE involved in the molecular regulation of neurotransmitter release. May play an important role in the synaptic function of specific neuronal ...
  7. [7]
    Complex gene organization of synaptic protein SNAP-25 in ...
    We report here that the SNAP-25 gene (Snap) in the fruit fly Drosophila melanogaster has a complex organization with eight exons spanning more than 120 kb ( ...
  8. [8]
    Evolutionary conservation of synaptosome-associated protein 25 ...
    These data show that SNAP-25 and synaptobrevin, which are both implicated in vesicle docking and/or membrane fusion, have both been highly conserved during ...
  9. [9]
    DNA Variation in the SNAP25 Gene Confers Risk to ADHD and Is ...
    Our data show that DNA variation at SNAP25 confers risk to ADHD and reduces the expression of the transcript in a region of the brain that is critical for the ...
  10. [10]
    Distribution and expression of SNAP-25 immunoreactivity in rat ...
    These experiments demonstrated that subsets of neurons expressed SNAP-25, and that several patterns of expression emerged: SNAP-25 expression in caudate nucleus ...
  11. [11]
    SNAP-25 is expressed in islets of Langerhans and is involved in ...
    Mar 15, 1995 · By immunolocalization and Western blot analysis, it is now shown that SNAP-25 is also expressed in pancreatic endocrine cells. Botulinum ...
  12. [12]
    SNAP25 protein expression summary - The Human Protein Atlas
    The RNA data was used to cluster genes according to their expression across tissues. Clusters contain genes that have similar expression patterns, and each ...
  13. [13]
    Regional and developmental brain expression patterns of SNAP25 ...
    Apr 28, 2011 · The extent of this up-regulation in SNAP25b expression was similar across cortex, cerebellum and hippocampus. The SNAP25 isoforms also displayed ...Missing: synaptogenesis | Show results with:synaptogenesis
  14. [14]
    Genome-wide analysis of repressor element 1 silencing ... - NIH
    Interestingly, SNAP25 and L1CAM showed greater REST occupancy than the other loci in the presence of either native or overexpressed REST. Closer inspection of ...
  15. [15]
    article Differential Promoter Methylation and Histone Modification ...
    Because it has been known that promoter methylation could contribute to the brain-specific expression of genes such as HSD11B2, SNAP25, and PCDH9, we also ...
  16. [16]
    SNAP-25 IS ALSO AN IRON-SULFUR PROTEIN - PubMed Central
    All SNARE proteins contain a sequence termed the SNARE motif which has a propensity to form coiled-coils [2]. A crystal structure showed that the core SNARE ...
  17. [17]
    The SNAP-25 Protein Family - ScienceDirect.com
    Nov 10, 2019 · SNAP-25 contains a short N-terminus, a SNARE-motif (SN1, Qb), a linker region, and a second SNARE-motif (SN2, Qc) (Fig. 2A). The linker region ...<|separator|>
  18. [18]
    Characterization of the Palmitoylation Domain of SNAP-25 - PubMed
    Mutation of Cys to Ser at positions 85, 88, 90, and 92 reduced the palmitoylation to 9, 21, 42, and 35% of the wild-type protein, respectively. Additional ...Missing: rich linker region 139-180 Cys88 Cys92
  19. [19]
    1JTH: Crystal structure and biophysical properties of a complex ...
    SNARE proteins are required for intracellular membrane fusion. In the neuron, the plasma membrane SNAREs syntaxin 1a and SNAP25 bind to VAMP2 found on ...Missing: domains motifs cysteine- rich linker palmitoylation
  20. [20]
    Human cDNA clones encoding two different isoforms of the nerve ...
    Although the two isoforms, SNAP-25a and SNAP-25b, differ by only 9 aa, this domain encodes the portion of the protein that is a substrate for post ...
  21. [21]
    SNAP-25 isoforms differentially regulate synaptic transmission and ...
    Apr 25, 2019 · The SNAP-25 proteins are expressed from a single copy gene as two developmentally regulated and complementary distributed splice variants termed ...
  22. [22]
    Developmental and plasticity-related differential expression of two ...
    In this article we study the relationship between the expression pattern of two recently identified isoforms of the 25-kD synaptosomal-associated protein (SNAP- ...
  23. [23]
    SNAP-25a and SNAP-25b Differently Mediate Interactions ... - PubMed
    May 1, 2018 · SNAP-25a and SNAP-25b differ in 9 amino acids. SNAP-25b binds Munc18-1 more efficiently, and Gβ2 is less captured by SNAP-25a.
  24. [24]
    Differential palmitoylation regulates intracellular patterning of SNAP25
    Apr 15, 2011 · SNAP25 is a peripheral membrane protein, and palmitoylation of a cluster of four cysteine residues mediates its stable association with the ...
  25. [25]
    SNAP-25 Is Targeted to the Plasma Membrane through a Novel ...
    The two isoforms of SNAP-25 (a and b) differ at nine residues within this region (24), and it has been proposed that these differences might confer ...
  26. [26]
    SNAP-25 phosphorylation at Ser187 regulates synaptic facilitation ...
    Aug 11, 2017 · One of the SNARE proteins, SNAP-25, is phosphorylated at the residue serine-187 by PKC, but its physiological significance has been unclear. To ...
  27. [27]
    Protein kinase C-dependent phosphorylation of synaptosome ...
    Protein kinase C-dependent phosphorylation of synaptosome-associated protein of 25 kDa at Ser187 potentiates vesicle recruitment. J Neurosci. 2002 Nov 1;22 ...<|separator|>
  28. [28]
    Intra-axonal Synthesis of SNAP25 Is Required for the Formation of ...
    Sep 26, 2017 · The stability of SNAP25 at presynapses is controlled by activity induced ubiquitination and proteasome-dependent degradation (Sheehan et al., ...
  29. [29]
    Targeting botulinum neurotoxin persistence by the ubiquitin ...
    Sep 21, 2010 · We describe chimeric SNAP25-based ubiquitin ligases that target BoNT/A LC for degradation, reducing its duration in a cellular model for toxin persistence.
  30. [30]
    The Hsc70 system maintains the synaptic SNARE protein SNAP-25 ...
    The SNARE complex and SNAP-25. A, crystal structure of the SNARE complex (PDB 1sfc ) depicting four helices from syntaxin (pink), synaptobrevin (blue), and SNAP ...
  31. [31]
    The Role of Co-chaperones in Synaptic Proteostasis and ... - PubMed
    May 19, 2017 · These three co-chaperones maintain client function by preserving folding and assembly to prevent client aggregation ... Hsc70, DNAJAs, and ...
  32. [32]
    Differential Control of the Releasable Vesicle Pools by SNAP-25 ...
    Our data show that all three SNARE proteins can support vesicular fusion and neurotransmitter release; however, the distinguishing feature of the SNAP-25 ...
  33. [33]
    SNAP-25a and SNAP-25b differently mediate interactions with ...
    May 1, 2018 · Adult mice almost exclusively express the SNAP-25b protein in hippocampus whereas SNAP-25b-deficient mice only express SNAP-25a.
  34. [34]
    Crystal structure of a SNARE complex involved in synaptic ... - PubMed
    Here we report the X-ray crystal structure at 2.4 A resolution of a core synaptic fusion complex containing syntaxin-1 A, synaptobrevin-II and SNAP-25B.
  35. [35]
    A dominant mutation in Snap25 causes impaired vesicle trafficking ...
    Both Vamp2 and Snap25 knockouts are perinatally lethal in homozygous mice, and heterozygotes show no apparent phenotype, so detailed analysis of viable ...
  36. [36]
    Science | AAAS
    - **Summary**: Insufficient relevant content. The provided URL (https://www.science.org/doi/10.1126/science.1248995) leads to a "Page not found" error, indicating the page is inaccessible or does not exist. No data on SNAP25, syntaxin, or VAMP2 copy numbers per synaptic bouton or synapse is available from the content.
  37. [37]
    The SNARE protein SNAP-25 is linked to fast calcium triggering of ...
    We conclude that the SNARE complex is linked directly to calcium triggering of exocytosis, most likely in a complex with auxiliary proteins.
  38. [38]
    Stimulation of NSF ATPase Activity by α-SNAP Is Required for ... - NIH
    In contrast, α-SNAP activation of NSF ATPase activity correlates well with SNARE disassembly, implying that NSF activation is essential for this process.
  39. [39]
    Structural remodeling of target-SNARE protein complexes by NSF ...
    Sep 24, 2025 · This approach improved the reconstruction of the spire proteins to 4.22 Å, enabling docking of a crystal structure of the 2:2 syntaxin—SNAP-25 ...
  40. [40]
    NSF-mediated disassembly of on- and off-pathway SNARE ... - eLife
    Jul 9, 2018 · We developed a single-molecule FRET assay to monitor repeated rounds of NSF-mediated disassembly and reassembly of individual SNARE complexes.
  41. [41]
    Munc18-1 binding to the neuronal SNARE complex controls ... - NIH
    Munc18-1 and soluble NSF attachment protein receptors (SNAREs) are critical for synaptic vesicle fusion. Munc18-1 binds to the SNARE syntaxin-1 folded into ...
  42. [42]
    SNAP25 disease mutations change the energy landscape for ... - eLife
    Complexin-II clamps spontaneous Ca2+-independent membrane fusion in the reconstituted assay (i.e. fusion before addition of Ca2+), via laterally binding the ...
  43. [43]
    The Hsc70 system maintains the synaptic SNARE protein SNAP-25 ...
    We hypothesize that Hsc70 and CSPα cooperate to chaperone SNAP-25, disfavoring its aggregation and keeping it in a folding state competent for SNARE complex ...
  44. [44]
    The Hsc70 system maintains the synaptic SNARE protein SNAP-25 ...
    The Hsc70 system maintains the synaptic SNARE protein SNAP-25 in an assembly-competent state and delays its aggregation. November 2024; Journal of Biological ...
  45. [45]
    SNAP-25 regulates spine formation through postsynaptic binding to ...
    Jul 19, 2013 · We demonstrate that SNAP-25 can recruit p140Cap and regulate density, morphology and functionality of dendritic spines.
  46. [46]
    SNAP-25b-deficiency increases insulin secretion and changes ...
    Aug 10, 2017 · SNAP-25 is a protein of the core SNARE complex mediating stimulus-dependent release of insulin from pancreatic β cells.
  47. [47]
    SNAP-25 is expressed in islets of Langerhans and ... - PubMed - NIH
    Botulinum neurotoxins (BoNT) A and E were used to study the role of SNAP-25 in insulin secretion. These neurotoxins inhibit transmitter release by cleaving SNAP ...
  48. [48]
    Structural remodeling of target-SNARE protein complexes by NSF ...
    Sep 24, 2025 · One target membrane SNARE, syntaxin, forms nanodomains at the active zone, and another, SNAP-25, enters non-fusogenic complexes with it. Here, ...
  49. [49]
    SNAP25 disease mutations change the energy landscape for ... - eLife
    Feb 27, 2024 · SNAP25 is one of three neuronal SNAREs driving synaptic vesicle exocytosis. We studied three mutations in SNAP25 that cause epileptic ...
  50. [50]
    De novo variants in SNAP25 cause an early-onset developmental ...
    We provide a comprehensive description of SNAP25-DEE with intellectual disability and early-onset epilepsy mostly occurring before the age of two years.Missing: DEE16 DEE58
  51. [51]
    616330 - DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY ...
    A novel missense SNAP25b mutation in two affected siblings from an Israeli family showing seizures and cerebellar ataxia.Missing: DEE16 DEE58
  52. [52]
    Synaptopathies in Developmental and Epileptic Encephalopathies
    Clinical features of SNAP25-related patients. No. Age of onset, Seizure type ... De novo variants in SNAP25 cause an early-onset developmental and epileptic ...
  53. [53]
    The Association of SNAP25 Gene Polymorphisms in Attention Deficit ...
    Mar 3, 2016 · In this study, we analyzed the possible association between six polymorphisms (rs3746544, rs363006, rs1051312, rs8636, rs362549, and ...
  54. [54]
    Association of SNAP-25 Gene Ddel and Mnll Polymorphisms ... - NIH
    Thus, at least it is possible that any variation in SNAP-25 might interfere in the susceptibility of ADHD by influencing the release of dopamine as well as ...
  55. [55]
    2.4 - Clinical Psychopharmacology and Neuroscience
    In addition, it was reported in a meta-analysis that the T allele of the 1065 T>G SNP is significantly associated with ADHD (odds ratio, 1.19; 95% confidence ...
  56. [56]
    Association between SNAP-25 gene polymorphisms and cognition ...
    Jan 27, 2015 · Reduction of SNAP-25 expression has been described in brains of patients affected by either schizophrenia or ADHD. Reduction of protein ...
  57. [57]
    A Multilevel Functional Study of a SNAP25 At-Risk Variant for ...
    Oct 25, 2017 · We recently identified a promoter variant in SNAP25, rs6039769, that is associated with early-onset bipolar disorder and a higher gene expression level in ...
  58. [58]
    A SNAP25 promoter variant is associated with early-onset bipolar ...
    These results show that variations in SNAP25, associated with an increased gene expression level in prefrontal cortex, might predispose to early-onset BD.Missing: rs603976 | Show results with:rs603976
  59. [59]
    Mutation in SNAP25 causes epilepsy & intellectual disability
    Early onset epileptic encephalopathy has been associated with mutations in ALDH7A1, ATP6AP2, PCDH19, POLG, PNPO, SLC2A1, SLC25A22, SPTAN1, and STXBP1.Missing: DEE16 DEE58
  60. [60]
    De novo variants in SNAP25 cause an early-onset developmental ...
    We provide a comprehensive description of SNAP25-DEE with intellectual disability and early-onset epilepsy mostly occurring before the age of two years.Missing: Ile171Thr | Show results with:Ile171Thr
  61. [61]
    Polygenic scores for autism are associated with reduced neurite ...
    Feb 24, 2025 · This study provides evidence for shared common variant genetics between autism and cortical neurite density.Missing: SNAP25 | Show results with:SNAP25
  62. [62]
    SNAP-25, a Known Presynaptic Protein with Emerging Postsynaptic ...
    SNAP-25 is a component of the SNARE protein complex, which is involved in the exocytotic release of neurotransmitters during synaptic transmission.Abstract · An Unexpected Role of SNAP... · SNAP-25, a Shared Biological...
  63. [63]
    Genetics of attention deficit hyperactivity disorder - Nature
    Jun 11, 2018 · For both the child and adult meta-analyses, the strength of each association, as measured by the odds ratio, is small, less than 1.5. Many ...
  64. [64]
    SNAP25 is a potential target for early stage Alzheimer's disease and ...
    Dec 6, 2023 · SNAP25 in the olfactory epithelium may serve as a potential target for early detection and intervention in both AD and PD.Missing: prodromal | Show results with:prodromal
  65. [65]
    A Novel ELISA for the Measurement of Cerebrospinal Fluid SNAP ...
    Nov 10, 2019 · We found that SNAP-25 levels were significantly decreased in patients with later stages of Alzheimer's disease compared with the controls (Fig.
  66. [66]
    Knock-in models related to Alzheimer's disease: synaptic ...
    Jul 15, 2021 · ... cleavage sites flanking the Aβ sequence and are ... Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease.
  67. [67]
    An Atypical, Staged Cell Death Pathway Induced by Depletion of ...
    Jan 18, 2023 · ... SNAP25, or MUNC18-1. The current study ... Cleavage of caspase 3 marks the end stage of apoptotic cell death where cleaved caspase ...
  68. [68]
    Protein regulatory network mediated by palmitoylation modifications ...
    Jul 8, 2025 · This review summarizes the emerging link between protein palmitoylation and PD pathogenesis. Understanding the dynamic regulatory mechanisms of palmitoylation ...
  69. [69]
    Upregulation of cellular palmitoylation mitigates α-synuclein ...
    We hypothesized that abnormal αS membrane-binding impairs trafficking by disrupting palmitoylation. Accordingly, we investigated the therapeutic potential of ...
  70. [70]
    Proteolysis of SNAP-25 by types E and A botulinal neurotoxins.
    BoNT/E cleaves the Arg180-Ile181 bond. This site is different from that of BoNT/A, which cleaves SNAP-25 between the amino acid residues Gln197 and Arg198.
  71. [71]
    Multiple Pocket Recognition of SNAP25 by Botulinum Neurotoxin ...
    The binding of SNAP25 to LC/E is facilitated through P1′ and P2 site interactions with the S1′ and S2 pockets of LC/E (D). Proper docking of P1′ and P2 sites ...
  72. [72]
    Article Botulinum Toxins A and E Inflict Dynamic Destabilization on t ...
    Nov 7, 2017 · Botulinum toxins (BoNTs) A and E block neurotransmitter release by specifically cleaving the C- terminal ends of SNAP-25, a plasma membrane SNARE protein.
  73. [73]
    Botulism - StatPearls - NCBI Bookshelf - NIH
    The flaccid paralysis of botulism results from the irreversible inhibition of acetylcholine release at the presynaptic nerve terminal of the body's ...
  74. [74]
    Infantile Botulism - StatPearls - NCBI Bookshelf - NIH
    Infantile botulism results from intestinal colonization by Clostridium botulinum, an anaerobic, spore-forming, gram-positive bacillus present in soil, water, ...Continuing Education Activity · Introduction · Epidemiology · Evaluation
  75. [75]
    [PDF] BOTOX (onabotulinumtoxinA) Label - accessdata.fda.gov
    Treatment of cervical dystonia with botulinum toxins may weaken neck muscles that serve as accessory muscles of ventilation. This may result in a critical loss ...
  76. [76]
    Botulinum Toxin in the Treatment of Headache - PMC - NIH
    Dec 17, 2020 · Botulinum toxin type A has been used in the treatment of chronic migraine for over a decade and has become established as a well-tolerated option.
  77. [77]
    Persistence of Botulinum Neurotoxin A Subtypes 1-5 in Primary Rat ...
    ... partial recovery of SNAP-25 cleavage at ∼11 weeks. Conversely, cells exposed to BoNT/E possess fully recovered SNAP-25 after ∼18 days [11]. The long-term ...
  78. [78]
    A Drosophila SNAP-25 null mutant reveals context-dependent ... - NIH
    The synaptic protein SNAP-25 is an important component of the neurotransmitter release machinery, although its precise function is still unknown.
  79. [79]
    Evolutionary Conservation of Synaptosome-Associated Protein 25 ...
    These data show that SNAP-25 and synaptobrevin, which are both implicated in vesicle docking and/or membrane fusion, have both been highly conserved during ...Missing: gene | Show results with:gene
  80. [80]
    Epileptiform Activity and Cognitive Deficits in SNAP-25+/− Mice are ...
    Oct 12, 2012 · These results indicate that reduction of SNAP-25 expression is associated to generation of epileptiform discharges and cognitive dysfunctions, ...Epileptiform Activity And... · Kainate-Induced Seizures · Results
  81. [81]
    Brain-Specific SNAP-25 Deletion Leads to Elevated Extracellular ...
    We showed that SNAP-25 conditional knockout (cKO) mice exhibited typical schizophrenia-like phenotype. A significantly elevated extracellular glutamate level ...
  82. [82]
    Genetic disorders of neurotransmitter release machinery - Frontiers
    Knockout of SNAP25 results in neonatal lethality due to respiratory failure caused by failed evoked release at the phrenic nerve terminals that innervate ...
  83. [83]
    Snap25 heterozygous knockout mice as a model for attention deficit ...
    In the LDB +/- mice entered the lit compartment of the arena earlier than the controls, thus showing attenuated anxiety-like behavior. Regarding depressive-like ...Missing: SNAP25B | Show results with:SNAP25B
  84. [84]
    miR-153 Regulates SNAP-25, Synaptic Transmission, and Neuronal ...
    We report a novel microRNA mechanism of SNAP-25 regulation controlling motor neuron development, neurosecretion, synaptic activity, and movement in zebrafish.
  85. [85]
    Seizing the moment: Zebrafish epilepsy models - ScienceDirect.com
    We seek to summarize the current knowledge about existing epilepsy/seizures models in zebrafish (both pharmacological and genetic) and compare them with ...
  86. [86]
    SNAP25 variant I67N: synaptic phenotypes, drug response and ...
    Here we generated CRISPR/Cas9-engineered human induced pluripotent stem-cell (hiPSC) lines carrying the pathogenic variant I67N in the SNAREopathy gene SNAP25.Missing: DEE | Show results with:DEE
  87. [87]
    Accessory proteins stabilize the acceptor complex for synaptobrevin ...
    Syntaxin and SNAP-25 often form a stable “dead-end” 2:1 complex in vitro where a second syntaxin SNARE domain takes the usual position of the synaptobrevin ...
  88. [88]
    Different regions of synaptic vesicle membrane regulate VAMP2 ...
    Mar 24, 2020 · The assembly of SNARE complex in neurons is driven by the formation of a stable four-helix bundle between VAMP2 (also known as synaptobrevin2), ...
  89. [89]
    Munc18-1 is crucial to overcome the inhibition of synaptic vesicle ...
    Sep 23, 2019 · Munc18-1 and Munc13-1 orchestrate assembly of the SNARE complex formed by syntaxin-1, SNAP-25 and synaptobrevin, allowing exquisite regulation of ...Missing: clamping | Show results with:clamping
  90. [90]
    Interactions Between SNAP-25 and Synaptotagmin-1 Are Involved ...
    Whether interactions between synaptotagmin-1 (syt-1) and the soluble NSF attachment protein receptors (SNAREs) are required during neurotransmission is debated.Missing: key | Show results with:key
  91. [91]
    SNAP-25 gene family members differentially support secretory ...
    To test if other SNAP homologs support DCV fusion, we expressed SNAP-23, SNAP-29 or SNAP-47 in SNAP-25 KO neurons. SNAP-23 and SNAP-29 rescued viability and ...
  92. [92]
    CytLEK1 Is a Regulator of Plasma Membrane Recycling through Its ...
    Using a yeast two-hybrid screen, we identify a novel interaction between SNAP-25 and cytoplasmic Lek1 (cytLEK1), a protein previously demonstrated to associate ...
  93. [93]
    Spring, a Novel RING Finger Protein That Regulates Synaptic ...
    ... SNAP-25-binding proteins using a yeast two-hybrid screen. We report here the isolation of a novel RING finger protein, termed Spring, that specifically ...
  94. [94]
  95. [95]
    Energetics, kinetics, and pathways of SNARE assembly in ...
    Here, we review recent progress in understanding SNARE assembly and membrane fusion, with a focus on results obtained by single-molecule manipulation approaches ...
  96. [96]
  97. [97]
  98. [98]
  99. [99]
  100. [100]